Prune belly syndrome (PBS), also called Eagle-Barrett syndrome or triad syndrome, is a rare congenital disorder classically defined by a triad of deficiency or absence of the anterior abdominal wall musculature, urinary tract abnormalities (a massively dilated poorly contractile bladder, dilated tortuous ureters, hydronephrosis, and vesicoureteral reflux), and bilateral intra-abdominal cryptorchidism in males. The wrinkled, lax appearance of the neonatal abdominal wall gives the syndrome its name. PBS occurs predominantly in males, most cases are sporadic with a normal karyotype, and it is a member of the group of fetal lower urinary tract obstruction (LUTO)-associated disorders. Severity spans a wide spectrum, from stillbirth or early neonatal death from pulmonary and renal insufficiency to milder phenotypes with near-normal renal function. The etiology remains unknown; the two principal pathogenic hypotheses are a primary urethral-obstruction / bladder-distension mechanism and a primary mesodermal developmental defect, and recent work implicates disordered genitourinary smooth-muscle myogenesis.
Ask a research question about Prune Belly Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Prune Belly Syndrome
category: Complex
creation_date: "2026-07-19T00:00:00Z"
synonyms:
- Eagle-Barrett syndrome
- Triad syndrome
- Abdominal muscle deficiency syndrome
- Obrinsky syndrome
description: >
Prune belly syndrome (PBS), also called Eagle-Barrett syndrome or triad
syndrome, is a rare congenital disorder classically defined by a triad of
deficiency or absence of the anterior abdominal wall musculature, urinary
tract abnormalities (a massively dilated poorly contractile bladder, dilated
tortuous ureters, hydronephrosis, and vesicoureteral reflux), and bilateral
intra-abdominal cryptorchidism in males. The wrinkled, lax appearance of the
neonatal abdominal wall gives the syndrome its name. PBS occurs predominantly
in males, most cases are sporadic with a normal karyotype, and it is a member
of the group of fetal lower urinary tract obstruction (LUTO)-associated
disorders. Severity spans a wide spectrum, from stillbirth or early neonatal
death from pulmonary and renal insufficiency to milder phenotypes with
near-normal renal function. The etiology remains unknown; the two principal
pathogenic hypotheses are a primary urethral-obstruction / bladder-distension
mechanism and a primary mesodermal developmental defect, and recent work
implicates disordered genitourinary smooth-muscle myogenesis.
disease_term:
preferred_term: prune belly syndrome
term:
id: MONDO:0007032
label: prune belly syndrome
parents:
- congenital abnormality
- urinary system disease
mappings:
mondo_mappings:
- term:
id: MONDO:0007032
label: prune belly syndrome
mapping_predicate: skos:exactMatch
mapping_source: OMIM:100100
mapping_justification: >
MONDO:0007032 cross-references OMIM:100100 and Orphanet:2970 for prune
belly syndrome / Eagle-Barrett syndrome.
inheritance:
- name: Predominantly sporadic occurrence
description: >
Most cases of prune belly syndrome are sporadic and occur in individuals
with a normal karyotype, with a strong male predominance. Familial
clustering, twin concordance, and rare single-gene and chromosomal findings
indicate genetic heterogeneity rather than a single Mendelian mode of
inheritance.
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Most cases of PBS are sporadic and have a normal karyotype, with 95% patients being male."
explanation: Establishes the predominantly sporadic occurrence and male predominance.
- reference: PMID:38879764
reference_title: "Prune-belly Syndrome: An Update."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "congenital and genetically \nheterogeneous disease"
explanation: PBS is described as a congenital and genetically heterogeneous disease.
prevalence:
- population: Live male births (United States national database)
measure_type: BIRTH_PREVALENCE
prevalence_class: BAND_1_9_PER_100000
rate_per_100000: 3.8
notes: >
3.8 per 100,000 live male births; strong male predominance (~95% of cases
are male). PBS occurs in roughly 1 in 30,000-40,000 births overall.
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "a severe multisystem congenital anomaly complex affecting 3.8 per 100,000 live male births"
explanation: Provides the population birth-prevalence estimate in live male births.
mechanistic_hypotheses:
- hypothesis_group_id: urethral_obstruction_theory
hypothesis_label: Urethral obstruction / bladder-distension theory
status: EMERGING
description: >
Transient fetal urethral obstruction (or functional lower urinary tract
obstruction) causes massive bladder distension and ascites, which
secondarily damages the developing abdominal wall musculature, prevents
testicular descent, and produces upper-tract dilation and renal dysplasia.
This is one of the two long-standing competing explanations for the triad.
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the second theory, involving in utero bladder obstruction, a
hypoplastic/dysplastic prostate or abnormal urethra prevents urine
passage. This obstruction of urine flow causes bladder, ureteral and renal
distention with secondary abdominal wall and urinary muscle maldevelopment.
explanation: Directly states the proposed obstruction mechanism and its downstream developmental effects.
- hypothesis_group_id: mesodermal_defect_theory
hypothesis_label: Primary mesodermal developmental defect theory
status: EMERGING
description: >
A primary defect of intermediate/lateral-plate mesoderm between the 6th and
10th weeks of gestation simultaneously impairs abdominal wall muscle, the
genitourinary smooth muscle and urinary tract, and gonadal descent,
accounting for the triad without requiring mechanical obstruction. Recent
identification of variants in genes regulating genitourinary myogenesis
supports a primary developmental-myopathic mechanism.
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the first theory, known as the theory of mesodermal arrest, an unknown
primary defect in the development of the lateral plate mesoderm between 6
and 10 weeks of gestation produces primary maldevelopment of the abdominal
wall and urinary tract musculature.
explanation: Directly states the timing and structures implicated by the mesodermal-arrest hypothesis.
pathophysiology:
- name: Primary mesodermal developmental arrest
description: >
Under the mesodermal-arrest hypothesis, abnormal somatic and splanchnic
mesoderm development during weeks 6-10 impairs formation of the abdominal
wall, urinary-tract musculature, and gubernaculum.
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the first theory, known as the theory of mesodermal arrest, an unknown
primary defect in the development of the lateral plate mesoderm between 6
and 10 weeks of gestation produces primary maldevelopment of the abdominal
wall and urinary tract musculature.
explanation: Defines the proposed primary mesodermal developmental event.
downstream:
- target: Abnormal genitourinary smooth-muscle development
description: The proposed mesodermal defect impairs urinary-tract muscle development.
causal_link_type: DIRECT
hypothesis_groups:
- mesodermal_defect_theory
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the first theory, known as the theory of mesodermal arrest, an unknown
primary defect in the development of the lateral plate mesoderm between 6
and 10 weeks of gestation produces primary maldevelopment of the abdominal
wall and urinary tract musculature.
explanation: The cited hypothesis directly links mesodermal arrest to urinary-tract muscle maldevelopment.
- target: Deficiency of the abdominal wall musculature
description: The same proposed mesodermal defect impairs abdominal-wall muscle development.
causal_link_type: DIRECT
hypothesis_groups:
- mesodermal_defect_theory
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the first theory, known as the theory of mesodermal arrest, an unknown
primary defect in the development of the lateral plate mesoderm between 6
and 10 weeks of gestation produces primary maldevelopment of the abdominal
wall and urinary tract musculature.
explanation: The cited hypothesis directly links mesodermal arrest to abdominal-wall muscle maldevelopment.
- target: Bilateral cryptorchidism
description: Gubernacular maldevelopment is proposed to impair testicular descent.
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
intermediate_mechanisms:
- abnormal gubernaculum development
hypothesis_groups:
- mesodermal_defect_theory
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Maldevelopment of the somatic and splanchnic mesoderm results in
dysplastic or absent muscle of the abdominal wall, urinary tract, and
gubernaculum7.
explanation: The hypothesis includes gubernacular maldevelopment, a known intermediate in failed testicular descent.
- name: MYOCD-associated impaired smooth-muscle differentiation
description: >
MYOCD is a master transcriptional coactivator for smooth-muscle
differentiation. PBS/megabladder-associated MYOCD variants and mutant mouse
models implicate impaired embryonic smooth-muscle differentiation in a
subset of cases.
cell_types:
- preferred_term: smooth muscle cell
term:
id: CL:0000192
label: smooth muscle cell
biological_processes:
- preferred_term: smooth muscle tissue development
modifier: DECREASED
term:
id: GO:0048745
label: smooth muscle tissue development
genes:
- preferred_term: MYOCD
term:
id: hgnc:16067
label: MYOCD
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In 2019, Houwelinget al.11published a series of 4 unrelated multiplex
families (7 affected males from 3 families) with megabladder harboring
heterozygous truncation or missense mutations or microdeletion in the
MYOCD gene.
explanation: Reports MYOCD variants in multiple affected families.
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
In addition, the authors showed two genetically engineered compound
heterozygous mutant mouse models with altered MYOCD production that had
the megabladder phenotype.
explanation: Mutant mouse models reproduce megabladder.
downstream:
- target: Abnormal genitourinary smooth-muscle development
description: Altered MYOCD production is proposed to impair smooth-muscle differentiation in the urinary tract.
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
intermediate_mechanisms:
- altered serum response factor-dependent transcription
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
MYOCD is a critical smooth- and cardiac-specific master regulatory
cofactor of serum response factor that binds promoters and activates
transcription of many smooth muscle genes, leading to vascular and
visceral smooth muscle cell differentiation in during embryonic development.
explanation: Establishes MYOCD's role in the transcriptional program for embryonic smooth-muscle differentiation.
- name: Impaired PIEZO1-mediated pressure sensing
description: >
Compound-heterozygous PIEZO1 variants reported in one PBS patient reduce
pressure-induced channel open probability without changing single-channel
current, indicating impaired mechanosensation.
locations:
- preferred_term: lower urinary tract
term:
id: UBERON:0001556
label: lower urinary tract
genes:
- preferred_term: PIEZO1
term:
id: hgnc:28993
label: PIEZO1
evidence:
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
loss-of-function characteristics in the pressure-induced normalized open
probability (NPo) of the channel, while no change is observed in
single-channel currents. Furthermore, Yoda1, a PIEZO1 activator, can
rescue the NPo defect of the PBS mutant channels.
explanation: Functional analysis directly demonstrates defective pressure-induced channel opening and in-vitro rescue.
downstream:
- target: Poor urinary-tract contractility
description: Impaired pressure sensing is a candidate route to dysfunctional lower-urinary-tract smooth muscle.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
PIEZO1 is a cation-selective channel activated by various mechanical
forces and widely expressed throughout the lower urinary tract.
explanation: Supports lower-urinary-tract localization and mechanosensory function, while the contractility bridge remains incompletely resolved.
- name: Impaired CHRM3-mediated detrusor signaling
description: >
Biallelic CHRM3 loss of function disrupts M3 muscarinic receptor signaling
in bladder muscle and causes a familial congenital bladder malformation with
a prune-belly-like phenotype.
locations:
- preferred_term: urinary bladder
term:
id: UBERON:0001255
label: urinary bladder
genes:
- preferred_term: CHRM3
term:
id: hgnc:1952
label: CHRM3
evidence:
- reference: PMID:22077972
reference_title: "Muscarinic Acetylcholine Receptor M3 Mutation Causes Urinary Bladder Disease and a Prune-Belly-like Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
muscarinic acetylcholine receptor M3 (CHRM3) (1q41-q44) homozygous
frameshift mutation in familial congenital bladder malformation associated
with a prune-belly-like syndrome, defining an isolated gene defect
underlying this sometimes devastating disease.
explanation: Links biallelic CHRM3 loss of function to the familial prune-belly-like bladder phenotype.
downstream:
- target: Poor urinary-tract contractility
description: Loss of M3 receptor signaling impairs detrusor contraction.
causal_link_type: DIRECT
evidence:
- reference: PMID:22077972
reference_title: "Muscarinic Acetylcholine Receptor M3 Mutation Causes Urinary Bladder Disease and a Prune-Belly-like Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
CHRM3 encodes the M3 muscarinic acetylcholine receptor, which we show is
present in developing renal epithelia and bladder muscle. These
observations may imply that M3 has a role beyond its known contribution
to detrusor contractions.
explanation: Establishes expression in bladder muscle and the receptor's known contribution to detrusor contraction.
- name: Abnormal genitourinary smooth-muscle development
description: >
Reduced or dysplastic urinary-tract smooth muscle and increased fibrous
connective tissue impair ureteral peristalsis and bladder function.
locations:
- preferred_term: ureter
term:
id: UBERON:0000056
label: ureter
- preferred_term: urinary bladder
term:
id: UBERON:0001255
label: urinary bladder
cell_types:
- preferred_term: smooth muscle cell
term:
id: CL:0000192
label: smooth muscle cell
biological_processes:
- preferred_term: smooth muscle tissue development
modifier: ABNORMAL
term:
id: GO:0048745
label: smooth muscle tissue development
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Histologic ureteral evaluation demonstrates decrease and dysplasia of
smooth muscle cells and increase in fibrous connective tissue, both
contributing to the poor peristalsis13.
explanation: Histology directly links abnormal ureteral smooth muscle and fibrosis to poor peristalsis.
downstream:
- target: Poor urinary-tract contractility
description: Dysplastic smooth muscle impairs ureteral peristalsis and bladder emptying.
causal_link_type: DIRECT
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Histologic ureteral evaluation demonstrates decrease and dysplasia of
smooth muscle cells and increase in fibrous connective tissue, both
contributing to the poor peristalsis13.
explanation: Directly associates the structural smooth-muscle abnormality with impaired peristalsis.
- name: Fetal lower urinary tract obstruction
description: >
Under the competing obstruction hypothesis, a hypoplastic or dysplastic
prostate or abnormal urethra prevents fetal urine passage and causes
downstream urinary-tract distension.
locations:
- preferred_term: urinary bladder
term:
id: UBERON:0001255
label: urinary bladder
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the second theory, involving in utero bladder obstruction, a
hypoplastic/dysplastic prostate or abnormal urethra prevents urine passage.
explanation: Directly states the proposed anatomic basis of fetal obstruction.
downstream:
- target: Urinary tract dilation
description: Obstructed fetal urine flow distends the bladder, ureters, and kidneys.
causal_link_type: DIRECT
hypothesis_groups:
- urethral_obstruction_theory
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This obstruction of urine flow causes bladder, ureteral and renal
distention with secondary abdominal wall and urinary muscle maldevelopment.
explanation: The obstruction hypothesis directly predicts multilevel urinary-tract distension.
- target: Deficiency of the abdominal wall musculature
description: Fetal urinary distension is proposed to secondarily disrupt abdominal-wall muscle development.
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
intermediate_mechanisms:
- fetal bladder and abdominal distension
hypothesis_groups:
- urethral_obstruction_theory
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This obstruction of urine flow causes bladder, ureteral and renal
distention with secondary abdominal wall and urinary muscle maldevelopment.
explanation: The cited hypothesis explicitly describes secondary abdominal-wall maldevelopment.
- target: Reduced amniotic fluid volume
description: Severe fetal urinary obstruction can reduce urine-derived amniotic fluid.
causal_link_type: DIRECT
hypothesis_groups:
- urethral_obstruction_theory
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The first theory proposes an earlyin uteroposterior urethral obstruction
resulting in severe dilation of urinary tract and possible fetal ascites
and oligohydramnios6.
explanation: The reviewed obstruction hypothesis includes oligohydramnios as a downstream consequence.
- name: Poor urinary-tract contractility
description: >
Dysfunctional urinary smooth muscle produces poor ureteral peristalsis and
variably ineffective emptying of a large-capacity bladder.
locations:
- preferred_term: urinary bladder
term:
id: UBERON:0001255
label: urinary bladder
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Prune belly syndrome (PBS) is characterized by the triad of 1) lax
“prune-like” abdominal wall secondary to deficient abdominal wall skeletal
musculature, 2) urinary tract distension from dysfunctional smooth muscle,
and 3) intra-abdominal testes1,2.
explanation: Directly identifies dysfunctional smooth muscle as the basis of urinary-tract distension.
downstream:
- target: Urinary tract dilation
description: Poor peristalsis and bladder emptying promote diffuse urinary-tract distension.
causal_link_type: DIRECT
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Prune belly syndrome (PBS) is characterized by the triad of 1) lax
“prune-like” abdominal wall secondary to deficient abdominal wall skeletal
musculature, 2) urinary tract distension from dysfunctional smooth muscle,
and 3) intra-abdominal testes1,2.
explanation: Directly links dysfunctional urinary smooth muscle to tract distension.
- name: Urinary tract dilation
description: >
PBS produces variably severe dilation across the bladder, ureters, and renal
collecting systems, manifested as megacystis, hydroureter, and hydronephrosis.
locations:
- preferred_term: ureter
term:
id: UBERON:0000056
label: ureter
evidence:
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "urinary tract dilation with \npoorly contractile smooth muscle"
explanation: Describes diffuse urinary-tract dilation as a cardinal PBS feature.
downstream:
- target: Megacystis
description: Urinary-tract dilation includes marked bladder enlargement.
causal_link_type: DIRECT
evidence:
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "megabladder, megaureter, hydronephrosis, etc"
explanation: Names megabladder as a component of the PBS urinary-dilation phenotype.
- target: Hydroureter
description: Urinary-tract dilation includes enlarged, tortuous ureters.
causal_link_type: DIRECT
evidence:
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "megabladder, megaureter, hydronephrosis, etc"
explanation: Names megaureter as a component of the PBS urinary-dilation phenotype.
- target: Hydronephrosis
description: Urinary-tract dilation extends to the renal collecting systems.
causal_link_type: DIRECT
evidence:
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "megabladder, megaureter, hydronephrosis, etc"
explanation: Names hydronephrosis as a component of the PBS urinary-dilation phenotype.
- target: Recurrent urinary tract infections
description: Obstruction, reflux, and poor emptying promote infection and renal scarring.
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
intermediate_mechanisms:
- ureteric obstruction, vesicoureteral reflux, and bladder dysfunction
evidence:
- reference: PMID:30018947
reference_title: Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Most patients develop renal dysfunction due to congenital renal
dysplasia and/or scarring from urinary tract infections resulting from
ureteric obstruction, VUR, or bladder dysfunction.
explanation: Links the abnormal urinary tract to infection-associated renal scarring.
- target: Progressive kidney injury
description: Obstruction, reflux, bladder dysfunction, and infection can scar the kidneys.
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
intermediate_mechanisms:
- vesicoureteral reflux and urinary tract infection
evidence:
- reference: PMID:30018947
reference_title: Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Most patients develop renal dysfunction due to congenital renal
dysplasia and/or scarring from urinary tract infections resulting from
ureteric obstruction, VUR, or bladder dysfunction.
explanation: Directly supports renal dysfunction and scarring downstream of PBS uropathy.
- name: Congenital renal parenchymal dysplasia
description: >
Congenital renal parenchymal dysplasia is present in approximately half of
cases and independently contributes to impaired kidney function.
locations:
- preferred_term: kidney
term:
id: UBERON:0002113
label: kidney
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "renal dysplasia, which is present in 50% of cases"
explanation: Quantifies congenital renal dysplasia in PBS.
downstream:
- target: Renal dysplasia
description: Congenital parenchymal maldevelopment is clinically recognized as renal dysplasia.
causal_link_type: DIRECT
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "renal dysplasia, which is present in 50% of cases"
explanation: Directly documents renal dysplasia in PBS.
- target: Progressive kidney injury
description: Congenital dysplasia reduces renal reserve and contributes to kidney dysfunction.
causal_link_type: DIRECT
evidence:
- reference: PMID:30018947
reference_title: Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Most patients develop renal dysfunction due to congenital renal
dysplasia and/or scarring from urinary tract infections resulting from
ureteric obstruction, VUR, or bladder dysfunction.
explanation: Explicitly identifies congenital renal dysplasia as a cause of renal dysfunction in PBS.
- name: Progressive kidney injury
description: >
Congenital dysplasia together with obstructive, refluxing, and
infection-associated renal injury drives progressive loss of kidney function.
locations:
- preferred_term: kidney
term:
id: UBERON:0002113
label: kidney
evidence:
- reference: PMID:37968538
reference_title: "Kidney function and transplants in prune belly syndrome: a scoping review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "an estimated prevalence of CKD ranging from 8 to 66%"
explanation: Quantifies the substantial CKD burden across PBS cohorts.
downstream:
- target: Chronic kidney disease
description: Persistent renal injury manifests clinically as chronic kidney disease.
causal_link_type: DIRECT
evidence:
- reference: PMID:37968538
reference_title: "Kidney function and transplants in prune belly syndrome: a scoping review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "an estimated prevalence of CKD ranging from 8 to 66%"
explanation: Documents chronic kidney disease across PBS cohorts.
- name: Reduced amniotic fluid volume
description: >
Severe renal dysplasia or functional fetal bladder obstruction reduces
urine-derived amniotic fluid, producing oligohydramnios.
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Pulmonary hypoplasia results from oligohydramnios secondary to renal
dysplasia or to functional bladder obstruction, eventually causing newborn demise.
explanation: Identifies renal dysplasia and functional obstruction as causes of oligohydramnios in PBS.
downstream:
- target: Oligohydramnios
description: Reduced urine-derived amniotic fluid is clinically observed as oligohydramnios.
causal_link_type: DIRECT
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Pulmonary hypoplasia results from oligohydramnios secondary to renal
dysplasia or to functional bladder obstruction, eventually causing newborn demise.
explanation: Directly describes oligohydramnios secondary to PBS urinary pathology.
- target: Pulmonary hypoplasia
description: Oligohydramnios impairs fetal lung development and can cause lethal pulmonary hypoplasia.
causal_link_type: DIRECT
evidence:
- reference: PMID:2602227
reference_title: "Prune belly syndrome: clinicopathologic study of 29 cases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Severe urinary tract maldevelopment and pulmonary hypoplasia as part of
the oligohydramnios syndrome was the most common cause of perinatal deaths.
explanation: PBS-specific clinicopathologic evidence links oligohydramnios syndrome to pulmonary hypoplasia and perinatal death.
phenotypes:
- name: Deficiency of the abdominal wall musculature
frequency: VERY_FREQUENT
diagnostic: true
description: >
Partial or complete absence/hypoplasia of the anterior abdominal wall
musculature produces the characteristic lax, wrinkled "prune-like" abdomen.
phenotype_term:
preferred_term: Aplasia/Hypoplasia of the abdominal wall musculature
term:
id: HP:0010318
label: Aplasia/Hypoplasia of the abdominal wall musculature
evidence:
- reference: PMID:38879764
reference_title: "Prune-belly Syndrome: An Update."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "defined by the clinical triad \n(1) deficiency of abdominal muscles"
explanation: Deficiency of abdominal muscles is the first component of the defining triad.
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "wrinkled flaccid ventral abdominal wall with \nskeletal muscle deficiency"
explanation: Describes the wrinkled, flaccid abdominal wall with muscle deficiency.
- name: Bilateral cryptorchidism
frequency: VERY_FREQUENT
diagnostic: true
description: >
Bilateral intra-abdominal undescended testes are a cardinal feature in
affected males and contribute to reduced fertility.
phenotype_term:
preferred_term: Bilateral cryptorchidism
term:
id: HP:0008689
label: Bilateral cryptorchidism
evidence:
- reference: PMID:38879764
reference_title: "Prune-belly Syndrome: An Update."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "(2) bilateral cryptorchidism"
explanation: Bilateral cryptorchidism is the second component of the defining triad.
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "intra-abdominal undescended testes"
explanation: Confirms intra-abdominal undescended testes as a cardinal feature.
- name: Megacystis
frequency: VERY_FREQUENT
diagnostic: true
description: >
A large-capacity, thin-walled, poorly contractile bladder with high residual
volumes; often first detected as fetal megacystis on prenatal ultrasound.
phenotype_term:
preferred_term: Megacystis
term:
id: HP:0000021
label: Megacystis
evidence:
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "megabladder, megaureter, hydronephrosis, etc"
explanation: The enlarged bladder (megabladder/megacystis) is a cardinal urinary feature of PBS.
- name: Hydroureter
frequency: FREQUENT
description: >
Dilated, tortuous, and elongated ureters are typical, reflecting the
dilated, poorly draining upper urinary tract.
phenotype_term:
preferred_term: Hydroureter
term:
id: HP:0000072
label: Hydroureter
evidence:
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "megabladder, megaureter, hydronephrosis, etc"
explanation: Dilated ureters (megaureter) are part of the diffuse urinary tract dilation of PBS.
- name: Hydronephrosis
frequency: FREQUENT
description: >
Dilation of the renal pelvis and calyces from the dilated, refluxing, or
obstructed upper urinary tract.
phenotype_term:
preferred_term: Hydronephrosis
term:
id: HP:0000126
label: Hydronephrosis
evidence:
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "megabladder, megaureter, hydronephrosis, etc"
explanation: Hydronephrosis is part of the diffuse upper urinary tract dilation of PBS.
- name: Vesicoureteral reflux
frequency: FREQUENT
description: >
High-grade vesicoureteral reflux is common and contributes to urinary
stasis, recurrent infection, and renal injury.
phenotype_term:
preferred_term: Vesicoureteral reflux
term:
id: HP:0000076
label: Vesicoureteral reflux
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Vesicoureteral reflux (VUR) is present in 75% of children with PBS"
explanation: Directly quantifies the high frequency of vesicoureteral reflux in PBS.
- name: Renal dysplasia
frequency: FREQUENT
description: >
Dysplastic renal parenchyma frequently coexists with the dilated urinary
tract and is a key determinant of baseline renal function.
phenotype_term:
preferred_term: Renal dysplasia
term:
id: HP:0000110
label: Renal dysplasia
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "renal dysplasia, which is present in 50% of cases"
explanation: Directly quantifies renal dysplasia occurring in half of PBS cases.
- name: Chronic kidney disease
frequency: FREQUENT
description: >
Progressive chronic kidney disease is the principal long-term morbidity,
with a substantial fraction of patients ultimately requiring kidney
replacement therapy.
phenotype_term:
preferred_term: Chronic kidney disease
term:
id: HP:0012622
label: Chronic kidney disease
evidence:
- reference: PMID:37968538
reference_title: "Kidney function and transplants in prune belly syndrome: a scoping review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "at higher risk of \ndeveloping kidney dysfunction and requiring kidney replacement therapy"
explanation: PBS patients are at high risk of kidney dysfunction and kidney replacement therapy.
- reference: PMID:30018947
reference_title: Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Sixteen patients (36%) developed CKD of at least stage 3; 12 patients
(27%) had CKD stage 4–5.
explanation: Supports a FREQUENT CKD frequency band in a 45-patient cohort.
- name: Oligohydramnios
description: >
Severe renal dysplasia or functional fetal bladder obstruction can reduce
amniotic fluid volume and produce the oligohydramnios/Potter sequence.
phenotype_term:
preferred_term: Oligohydramnios
term:
id: HP:0001562
label: Oligohydramnios
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Pulmonary hypoplasia results from oligohydramnios secondary to renal
dysplasia or to functional bladder obstruction, eventually causing newborn demise.
explanation: Identifies oligohydramnios as a consequence of severe PBS urinary pathology.
- name: Pulmonary hypoplasia
frequency: OCCASIONAL
description: >
In severely affected fetuses, oligohydramnios produces pulmonary hypoplasia
and the Potter sequence, a leading cause of early neonatal death.
phenotype_term:
preferred_term: Pulmonary hypoplasia
term:
id: HP:0002089
label: Pulmonary hypoplasia
evidence:
- reference: PMID:2602227
reference_title: "Prune belly syndrome: clinicopathologic study of 29 cases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Severe urinary tract maldevelopment and pulmonary hypoplasia as part of
the oligohydramnios syndrome was the most common cause of perinatal deaths.
explanation: PBS-specific clinicopathologic evidence identifies pulmonary hypoplasia in the lethal oligohydramnios sequence.
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK544248/
reference_title: Prune Belly Syndrome - StatPearls - NCBI Bookshelf
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The first group (about 20% of all prune belly syndrome patients)
characteristically demonstrates severe renal and pulmonary hypoplasia, and
most babies are either stillborn or die shortly after birth.
explanation: Supports the OCCASIONAL frequency band and the association with early mortality.
- name: Premature birth
frequency: FREQUENT
description: Prematurity is common and contributes to neonatal respiratory and other morbidity.
phenotype_term:
preferred_term: Premature birth
term:
id: HP:0001622
label: Premature birth
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "43% of patients are born premature"
explanation: Directly quantifies prematurity above the FREQUENT threshold.
- name: Recurrent urinary tract infections
frequency: FREQUENT
description: >
Urinary stasis in the dilated, poorly draining, refluxing tract predisposes
to recurrent urinary tract infections.
phenotype_term:
preferred_term: Recurrent urinary tract infections
term:
id: HP:0000010
label: Recurrent urinary tract infections
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "recurrent urinary tract infection (UTI), impose further deterioration of renal function"
explanation: Recurrent UTI is a recognized complication that worsens renal function in PBS.
- name: Congenital cardiovascular anomaly
frequency: OCCASIONAL
description: >
Congenital cardiac malformations (e.g., patent ductus arteriosus, septal
defects, tetralogy of Fallot) occur in roughly a quarter of PBS patients as
part of the multisystem phenotype.
phenotype_term:
preferred_term: Abnormal heart morphology
term:
id: HP:0001627
label: Abnormal heart morphology
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "25% have congenital cardiovascular anomalies"
explanation: Quantifies congenital cardiovascular anomalies in a quarter of PBS patients.
- name: Abnormality of the musculoskeletal system
frequency: FREQUENT
description: >
Musculoskeletal abnormalities are common and include clubfoot, hip
dysplasia, scoliosis, and other findings, some related to fetal compression.
phenotype_term:
preferred_term: Abnormality of the musculoskeletal system
term:
id: HP:0033127
label: Abnormality of the musculoskeletal system
evidence:
- reference: PMID:2602227
reference_title: "Prune belly syndrome: clinicopathologic study of 29 cases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
a broader spectrum of other defects was found including musculoskeletal
(58%) and gastrointestinal (31%) abnormalities.
explanation: Quantifies musculoskeletal abnormalities at 58% in a clinicopathologic series.
- name: Talipes equinovarus
frequency: OCCASIONAL
description: >
Clubfoot (talipes equinovarus) is the most common musculoskeletal anomaly in
PBS, part of a broader spectrum that includes hip dysplasia and scoliosis,
partly attributable to fetal oligohydramnios/compression.
phenotype_term:
preferred_term: Talipes equinovarus
term:
id: HP:0001762
label: Talipes equinovarus
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "talipes equinovarus (26%), hip dysplasia (5%), and congenital scoliosis (4%)"
explanation: Quantifies talipes equinovarus and other musculoskeletal anomalies in PBS.
- name: Constipation
description: >
Chronic constipation is a lifelong problem, aggravated by the deficient
abdominal wall musculature impairing effective Valsalva/defecation, alongside
other gastrointestinal anomalies (e.g., malrotation).
phenotype_term:
preferred_term: Constipation
term:
id: HP:0002019
label: Constipation
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "constipation also becomes a lifelong problem"
explanation: Constipation is described as a lifelong problem in PBS.
- name: Abnormality of the gastrointestinal tract
frequency: FREQUENT
description: >
Gastrointestinal abnormalities form an important extra-genitourinary part of
the syndrome and may be inapparent at birth.
phenotype_term:
preferred_term: Abnormality of the gastrointestinal tract
term:
id: HP:0011024
label: Abnormality of the gastrointestinal tract
evidence:
- reference: PMID:2602227
reference_title: "Prune belly syndrome: clinicopathologic study of 29 cases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
a broader spectrum of other defects was found including musculoskeletal
(58%) and gastrointestinal (31%) abnormalities.
explanation: Quantifies gastrointestinal abnormalities at 31% in a clinicopathologic series.
genetic:
- name: MYOCD
association: Heterozygous truncation/missense/microdeletion in familial PBS with megabladder
gene_term:
preferred_term: MYOCD
term:
id: hgnc:16067
label: MYOCD
relationship_type: CAUSATIVE
notes: >
MYOCD (myocardin) is a smooth- and cardiac-specific master transcriptional
coactivator. Heterozygous truncating/missense variants or microdeletions were
identified in affected males from multiple PBS families with megabladder, and
genetically engineered compound-heterozygous mutant mice reproduce the
megabladder phenotype, making MYOCD one of the better-supported PBS genes.
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "with megabladder harboring heterozygous truncation or missense mutations or microdeletion in the MYOCD gene"
explanation: Reports MYOCD variants in affected males across multiple PBS families with megabladder.
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "genetically engineered compound heterozygous mutant mouse models with altered MYOCD production that had the megabladder phenotype"
explanation: Engineered MYOCD-mutant mice reproduce the megabladder phenotype, supporting causality.
- name: CHRM3
association: Biallelic loss-of-function causing a prune-belly-like congenital bladder disorder
gene_term:
preferred_term: CHRM3
term:
id: hgnc:1952
label: CHRM3
relationship_type: UNKNOWN
notes: >
CHRM3 encodes the M3 muscarinic acetylcholine receptor, the principal
mediator of detrusor smooth-muscle contraction. Biallelic (homozygous)
loss-of-function variants cause an autosomal recessive familial congenital
bladder malformation with a prune-belly-like syndrome; Chrm3-null mice
phenocopy the megacystis phenotype. Because the reported human entity is
explicitly prune-belly-like rather than unequivocal classic PBS, its
relationship to MONDO:0007032 remains uncertain.
evidence:
- reference: PMID:22077972
reference_title: "Muscarinic Acetylcholine Receptor M3 Mutation Causes Urinary Bladder Disease and a Prune-Belly-like Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "muscarinic acetylcholine receptor M3 (CHRM3) (1q41-q44) homozygous frameshift"
explanation: Reports a homozygous CHRM3 frameshift mutation in familial bladder malformation with a prune-belly-like syndrome.
- reference: PMID:22077972
reference_title: "Muscarinic Acetylcholine Receptor M3 Mutation Causes Urinary Bladder Disease and a Prune-Belly-like Syndrome."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "strikingly phenocopies Chrm3 null \nmutant mice"
explanation: Chrm3-null mice phenocopy the human phenotype, supporting CHRM3 causality.
- name: FLNA
association: Candidate X-linked hemizygous missense variants in surviving males
gene_term:
preferred_term: FLNA
term:
id: hgnc:3754
label: FLNA
relationship_type: UNKNOWN
notes: >
Hemizygous missense variants in the X-linked filamin A gene (FLNA) were
identified in three surviving males with PBS. FLNA encodes an
actin-crosslinking mechanosensing scaffold in smooth muscle. The study
reported no recurrent variant, lacked patient-derived functional tissue and
a PBS mouse model, and described FLNA as a proposed candidate gene; the
association therefore remains provisional.
evidence:
- reference: PMID:32085749
reference_title: "Prune belly syndrome in surviving males can be caused by Hemizygous missense mutations in the X-linked Filamin A gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Prune belly syndrome in surviving males can be caused by Hemizygous missense \nmutations in the X-linked Filamin A gene"
explanation: Reports X-linked FLNA hemizygous missense variants as a cause of PBS in surviving males.
- name: PIEZO1
association: Candidate causal biallelic loss-of-function variant
gene_term:
preferred_term: PIEZO1
term:
id: hgnc:28993
label: PIEZO1
relationship_type: UNKNOWN
notes: >
Compound-heterozygous loss-of-function variants in the mechanosensitive
cation channel PIEZO1 were identified in a PBS patient by whole-exome
sequencing, with functional studies showing reduced pressure-induced channel
activity that could be rescued in vitro by the PIEZO1 activator Yoda1.
Reported as a candidate causal gene from a single family.
evidence:
- reference: PMID:38184690
reference_title: "PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "PIEZO1 mutations may be causal for PBS"
explanation: Reports PIEZO1 loss-of-function variants as candidate causal lesions for PBS.
- name: HNF1B
association: Candidate gene; 17q12 deletions in rare cases
gene_term:
preferred_term: HNF1B
term:
id: hgnc:11630
label: HNF1B
relationship_type: DISPUTED
notes: >
HNF1B (TCF2) is a candidate gene: rare cases of PBS carry chromosome 17q12
deletions encompassing HNF1B, but large-scale screening found functionally
significant HNF1B point mutations to be uncommon.
evidence:
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "chromosome 17q12 deletions encompassing the HNF1β gene"
explanation: 17q12 deletions encompassing HNF1B make it a candidate gene for PBS.
- reference: PMID:22114815
reference_title: "Genetic basis of prune belly syndrome: screening for HNF1β gene."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
snippet: "functionally \nsignificant HNF1β mutations are uncommon in prune belly syndrome"
explanation: Large-scale screening argues against functionally significant HNF1B point mutations as a common cause.
diagnosis:
- name: Prenatal fetal ultrasonography
description: >
Fetal ultrasound can identify megacystis and upper-tract dilation with
findings that overlap other causes of fetal bladder-outlet obstruction.
diagnosis_term:
preferred_term: fetal ultrasonography
term:
id: NCIT:C222238
label: Fetal Ultrasound Imaging
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
PBS presents prenatally by fetal ultrasound with findings common to
bladder outlet obstruction, as in posterior urethral valves or
megacystis-megaureter syndrome1,2.
explanation: Supports fetal ultrasonography as a prenatal detection modality while noting overlap with other LUTO entities.
- name: Postnatal renal and bladder ultrasonography
description: >
Postnatal ultrasonography characterizes hydroureteronephrosis and bladder
anatomy; renography can further assess renal function and drainage.
diagnosis_term:
preferred_term: renal ultrasonography
term:
id: NCIT:C159885
label: Renal Ultrasound
evidence:
- reference: PMID:30018947
reference_title: Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Patients surviving the perinatal period (fetal period and up to 28 days of
age) underwent clinical and functional evaluation on presentation,
including ultrasonography and renography (20).
explanation: Documents postnatal ultrasonography and renography in the clinical evaluation of PBS.
- name: Voiding cystourethrography
description: >
VCUG assesses the bladder outlet, bladder morphology, urethral atresia or
megalourethra, and vesicoureteral reflux.
diagnosis_term:
preferred_term: voiding cystourethrography
evidence:
- reference: PMID:30018947
reference_title: Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Voiding cystourethrogram (VCUG) was performed to assess urethral and
bladder pathology including urethral atresia, megalourethra, VUR, and
bladder characteristics.
explanation: Directly describes the postnatal diagnostic information obtained by VCUG.
treatments:
- name: Bilateral orchiopexy
description: >
Surgical mobilization and fixation of the bilateral intra-abdominal testes
into the scrotum, frequently required in affected males.
treatment_term:
preferred_term: orchiopexy
term:
id: NCIT:C111066
label: Orchiopexy
target_phenotypes:
- preferred_term: Bilateral cryptorchidism
term:
id: HP:0008689
label: Bilateral cryptorchidism
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "as little as bilateral orchiopexies"
explanation: Bilateral orchiopexy is a core surgical management option in PBS.
- name: Abdominal wall and urinary tract reconstruction
description: >
Reconstructive surgery to correct the deficient abdominal wall and to
reconstruct the dilated urinary tract in selected patients.
treatment_term:
preferred_term: Reconstructive Surgery
term:
id: NCIT:C25351
label: Reconstructive Surgery
target_phenotypes:
- preferred_term: Deficiency of the abdominal wall musculature
term:
id: HP:0010318
label: Aplasia/Hypoplasia of the abdominal wall musculature
- preferred_term: Hydroureter
term:
id: HP:0000072
label: Hydroureter
- preferred_term: Vesicoureteral reflux
term:
id: HP:0000076
label: Vesicoureteral reflux
evidence:
- reference: PMID:34016542
reference_title: "Modern management of and update on prune belly syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Some \npatients require abdominal and urinary tract reconstruction"
explanation: Abdominal wall and urinary tract reconstruction is used in more severely affected patients.
- name: Antibiotic therapy for urinary tract infection
description: >
Antimicrobial treatment and prophylaxis to manage the recurrent urinary
tract infections that complicate the dilated, stasis-prone urinary tract.
treatment_term:
preferred_term: antibiotic therapy
term:
id: NCIT:C15620
label: Antibiotic Therapy
target_phenotypes:
- preferred_term: Recurrent urinary tract infections
term:
id: HP:0000010
label: Recurrent urinary tract infections
evidence:
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK544248/
reference_title: Prune Belly Syndrome - StatPearls - NCBI Bookshelf
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Urologists commonly recommend prophylactic antibiotics and elective
circumcision to minimize the risk of UTIs.
explanation: Directly supports antibiotic prophylaxis to reduce urinary tract infection risk.
- name: Kidney transplantation
description: >
Kidney replacement therapy, including kidney transplantation, for patients
who progress to end-stage kidney disease.
treatment_term:
preferred_term: organ transplantation
term:
id: NCIT:C15289
label: Organ Transplantation
target_phenotypes:
- preferred_term: Chronic kidney disease
term:
id: HP:0012622
label: Chronic kidney disease
evidence:
- reference: PMID:37968538
reference_title: "Kidney function and transplants in prune belly syndrome: a scoping review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A total of 15 studies (314 patients) described KRT, primary kidney
transplant, and outcomes.
explanation: Directly documents kidney replacement therapy and primary kidney transplantation in PBS cohorts.
- name: Vesicoamniotic shunting for selected fetal lower urinary tract obstruction
description: >
Prenatal vesicoamniotic shunting may be considered in carefully selected
fetuses with PBS and coexisting severe lower urinary tract obstruction, but
benefit remains uncertain and no established PBS-specific guidelines exist.
treatment_term:
preferred_term: vesicoamniotic shunting
target_phenotypes:
- preferred_term: Oligohydramnios
term:
id: HP:0001562
label: Oligohydramnios
evidence:
- reference: PMID:30018947
reference_title: Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
These reports suggest that prenatal shunting may in fact benefit the
subset of PBS patients who also suffer from LUTO. However, it is impossible
to identify this subset of patients prenatally with noninvasive methods.
Thus, prenatal intervention in this patient population remains
controversial, with no established guidelines.
explanation: Supports only cautious, selected use and explicitly documents uncertainty and lack of guidelines.
- name: Cutaneous vesicostomy for temporary bladder drainage
description: >
A cutaneous vesicostomy can temporarily drain a poorly emptying bladder
while an infant grows before later reconstructive surgery.
treatment_term:
preferred_term: Urinary Diversion
term:
id: NCIT:C91841
label: Urinary Diversion
target_phenotypes:
- preferred_term: Megacystis
term:
id: HP:0000021
label: Megacystis
evidence:
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK544248/
reference_title: Prune Belly Syndrome - StatPearls - NCBI Bookshelf
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Occasionally children will need temporizing urologic interventions such as
a cutaneous vesicostomy in order to safely drain the bladder while infants
grow in preparation for more definitive surgeries such as ureteral
reconstruction and reimplantation at a later age.
explanation: Directly supports vesicostomy as temporary bladder drainage before definitive reconstruction.
Overview: Prune Belly Syndrome (PBS) is a rare, complex congenital disorder classically defined by a triad: (1) deficiency/agenesis of the ventral abdominal wall musculature producing a wrinkled, "prune-like" skin appearance, (2) massive dilation of the urinary tract (megacystis, megaureter, hydronephrosis) with poorly contractile, collagen-replaced smooth muscle, and (3) bilateral intra-abdominal cryptorchidism in males. It is now understood as a multisystem congenital myopathy/mesenchymal disorder rather than an isolated urologic anomaly, with an estimated 75% of patients having additional anomalies of the cardiac, gastrointestinal, respiratory, and musculoskeletal systems (StatPearls, NBK544248).
Key identifiers: - OMIM: #100100 (PRUNE BELLY SYNDROME; PBS) — https://omim.org/entry/100100 - Orphanet: ORPHA:2970 - ICD-10-CM: Q79.4 (Prune belly syndrome) - MeSH: Prune Belly Syndrome - GARD: 7479
Synonyms: Eagle-Barrett syndrome, Obrinsky syndrome, Triad syndrome, Abdominal Muscle Deficiency Syndrome, Congenital Absence of the Abdominal Muscles, Fröhlich syndrome (rare usage), Abdominal muscular deficiency syndrome, Megacystis-megaureter-cryptorchidism.
Source of information: The evidence base is derived primarily from aggregated disease-level resources (OMIM, Orphanet, StatPearls, GeneReviews-style narrative reviews) supplemented by clinical case series/registries (e.g., ESPN/ERA-EDTA European dialysis registry, single-center surgical cohorts of 15–50 patients) and individual case reports/family reports for genetic findings (most causal-gene evidence derives from single consanguineous families or sporadic trios rather than large cohorts) (PMID:22077972; PMID:31441039; PMID:38184690; PMID:32085749).
Disease causal factors — two dominant, non-mutually-exclusive theories: 1. Mesenchymal (lateral plate mesoderm) developmental defect theory: A primary injury to the lateral plate mesoderm between gestational weeks 6–10 — the tissue from which the abdominal wall musculature, ureters, bladder, prostate, and gubernaculum all arise — produces the full triad as parallel, not sequential, malformations (StatPearls NBK544248; ScienceDirect "Etiology and pathogenesis of the prune belly syndrome"). 2. Urethral/bladder-outlet obstruction (obstructive uropathy) theory: A hypoplastic/dysplastic prostate or urethral anomaly (severe angulation at the prostatomembranous junction, or a hypoplastic-prostate "flap valve") obstructs urine outflow in utero, causing massive bladder distension that secondarily stretches and thins the abdominal wall and displaces the testes, with resultant oligohydramnios. Notably, most contemporary reviews conclude the urologic dilation is not a true fixed anatomic outlet obstruction, since post-mortem/post-natal series rarely find one (Medscape "Prune Belly Syndrome" pathophysiology overview; StatPearls NBK544248). 3. A minority "yolk sac" embryologic theory has also been proposed but is less supported (StatPearls NBK544248).
Genetic risk factors: - CHRM3 (cholinergic receptor muscarinic 3, chr 1q43) — homozygous/biallelic loss-of-function variants cause PBS or a Prune-Belly-like syndrome in consanguineous families (autosomal recessive). CHRM3 encodes the M3 muscarinic acetylcholine receptor, the major mediator of detrusor smooth-muscle contraction (PMID:22077972 — Weber S et al., Am J Hum Genet 2011;89(5):668-74: "Muscarinic Acetylcholine Receptor M3 Mutation Causes Urinary Bladder Disease and a Prune-Belly-like Syndrome"; a homozygous frameshift c.1173_1184delinsT (p.Pro392Alafs43) truncates the third intracellular loop in a consanguineous Turkish kindred with six affected brothers exhibiting megacystis with detrusor hyporeflexia). A second family with a homozygous missense variant (c.352G>A; p.Gly118Arg) causing familial urinary bladder disease with impaired pupillary light reflex (a recognized CHRM3 phenotype feature) was reported by Beaman et al. (PMID:31441039, Clin Genet 2019;96(6):515-520). Chrm3-null mice phenocopy the megabladder phenotype, supporting causality. - PIEZO1 — compound heterozygous loss-of-function variants (c.757G>A p.Gly253Arg; c.6584C>T p.Ser2195Leu) identified by whole-exome sequencing in a PBS proband; PIEZO1 is the dominant mechanosensitive ion channel in bladder smooth muscle (PIEZO2 is absent there). Electrophysiology showed reduced pressure-induced channel open probability (NPo) without altered single-channel conductance; the PIEZO1 agonist Yoda1 rescued the NPo defect in vitro, nominating a candidate small-molecule therapeutic mechanism (PMID:38184690, Nat Commun 2024). - FLNA (Filamin A, X-linked, Xq28) — hemizygous missense variants (p.A1448V, p.C2160R, p.G2236E) identified in surviving adult males with PBS, two of which map to the mechanosensing Ig19–21 region and enhance binding to β1-integrin tails; proposed as the first X-linked PBS mechanism, consistent with the strong male predominance (PMID:32085749, BMC Med Genet 2020;21:38, Iqbal NS, Jascur TA, Harrison SM, et al.). - HNF1B — screened in a PBS cohort; one variant found in ~3% of patients but judged functionally normal in reporter assays, so HNF1B is not considered a major PBS gene despite some deletion case reports (PMID:22114815, J Urol 2012). - ACTA2 / ACTG2 — heterozygous variants reported in single cases, including one child with PBS, congenital mydriasis, and cerebrovascular anomalies attributed to an ACTA2 mutation (PMID:24998021) — these smooth-muscle actin genes overlap mechanistically with visceral myopathy/megacystis-microcolon spectrum disorders. - STIM1 — also reported as a plausible single-case candidate gene. - Overall: "Five autosomal genes, including CHRM3, HNF1β, ACTA2, ACTG2 and STIM1, have been reported with potentially causal DNA variants, however these genes each only account for one or two PBS cases or one PBS multiplex consanguineous kindred" — the great majority of PBS remains genetically unsolved, and no candidate gene yet explains the strong male/X-linked-appearing predominance other than the recent FLNA report (PMID:32085749). - A CNV report*: a novel 16p11.2 duplication has been associated with PBS in a case report (PMC8496350).
Environmental / non-genetic risk factors: - Twin pregnancy: incidence in twins reported as ~4× higher than in singletons (search synthesis from multiple epidemiology sources; StatPearls NBK544248). - Younger maternal age associated with higher incidence (StatPearls NBK544248). - Race: twice as common in Black vs. White populations in some U.S. series. - In vitro fertilization (IVF): case reports of PBS (including in a female newborn) following IVF-induced pregnancy, suggesting assisted reproduction may be a risk-modifying exposure, though causality is not established (PMC10700981). - Monozygotic (MZ) twin pairs have been reported both concordant and discordant for PBS, indicating that inherited genetic variants alone cannot fully explain pathogenesis — in one discordant identical female twin pair, twin-twin transfusion physiology (fetal anasarca) was implicated as an environmental/hemodynamic contributor to abdominal wall laxity (NEJM 1983;308:275). A separate discordant MZ twin case found DNA hypomethylation at 6q24 (TNDM), IGF2R, DIRAS3, and PEG1 loci only in the affected twin, raising an epigenetic/stochastic contribution (Eur J Pediatr).
Protective factors: No genetic or environmental protective factors for PBS have been established in the literature reviewed; this is an area of unmet knowledge.
Gene-environment interactions: Not formally characterized; the co-occurrence of genetic lesions (CHRM3/PIEZO1/FLNA loss-of-function in bladder smooth muscle/mechanotransduction machinery) with mechanical/hemodynamic amplifiers (twinning, IVF, bladder over-distension) is suggestive but not mechanistically proven as an interaction.
| Phenotype | Type | Onset | Frequency | Notes / suggested HPO |
|---|---|---|---|---|
| Deficient/absent abdominal wall musculature, wrinkled "prune" skin | Physical/congenital malformation | Congenital, evident at birth | Defining (~100% in classic triad) | HP:0004298 (Abdominal wall muscle deficiency) — verify label via OAK before use |
| Megacystis / massively distended, poorly contractile bladder | Structural/urologic | Congenital (often prenatally detectable 2nd trimester) | Defining | Suggest HP term for "enlarged bladder" — verify exact HPO ID/label via OAK |
| Bilateral hydroureteronephrosis | Structural/urologic | Congenital | Almost universal | HP:0000126 (Hydronephrosis) — verify |
| Vesicoureteral reflux | Functional/urologic | Congenital | ~75% | Verify HPO term |
| Renal dysplasia | Structural | Congenital | ~50% | HP:0000110 (Renal dysplasia) — verify |
| Bilateral intra-abdominal cryptorchidism (males) | Physical/congenital | Congenital | Defining in males | HP:0000028 (Cryptorchidism) — verify |
| Prostatic hypoplasia with dilated prostatic urethra | Structural | Congenital | Common | — |
| Pulmonary hypoplasia | Structural/respiratory | Congenital (2° to oligohydramnios) | ~58% of associated-anomaly cases; dominant driver of perinatal mortality | HP:0002089 (Pulmonary hypoplasia) — verify |
| Cardiac anomalies (PDA, VSD, ASD, tetralogy of Fallot) | Structural | Congenital | ~25% | Verify individual HPO terms |
| GI anomalies (midgut malrotation, bowel atresia, anorectal anomalies, Hirschsprung disease, gastroschisis) | Structural | Congenital | ~24% | — |
| Musculoskeletal anomalies (scoliosis, talipes equinovarus/clubfoot, hip dysplasia, torticollis, contractures) | Structural | Congenital | ~22% | HP:0001762 (Talipes equinovarus) — verify |
| Recurrent urinary tract infection | Clinical/functional | Infancy onward | ~80% of patients have ≥1 documented UTI | — |
| Impaired pupillary constriction (CHRM3-related cases) | Physical sign | Congenital | Reported in CHRM3-mutation-positive families | Reflects shared muscarinic receptor smooth-muscle biology (iris sphincter) |
| Chronic constipation | Functional | Childhood onward | Common (impaired Valsalva from abdominal wall deficiency) | — |
| Chronic kidney disease / ESRD | Laboratory/functional | Childhood–adolescence | ~30% of survivors | — |
Onset/severity/progression: Onset is congenital in essentially all cases; severity spans from lethal perinatal disease (Woodard/severity Category I) to mild, near-normal-life disease (Category III) — see Section 8 and 11. Course for the urinary tract component is generally progressive with respect to renal function in the more severe categories, but many patients with normal early renal function have a stable course into adulthood. A validated phenotypic severity scoring system (RUBACE — renal, ureter, bladder, abdominal wall, cryptorchidism, and other anomalies) has been developed and correlates with the Woodard categories (mean RUBACE scores 20.5, 13.8, and 10.6 for Categories 1, 2, 3 respectively) (PMID:30113772, Wong et al., BJU Int 2019).
Quality of life: Long-term studies of adults with PBS describe "good health-related quality of life and good social and sexual function," with patients participating in conventional physical, sexual, emotional, educational, and employment roles — except that patients who progress to require kidney transplantation score significantly lower on multiple QoL indices (multiple sources synthesized from Journal of Urology/Journal of Pediatric Urology adult-outcome literature).
Causal genes (biallelic/monogenic, each accounting for only single families/cases): - CHRM3 (HGNC:2733; OMIM 118494) — chr 1q43; loss-of-function (frameshift, missense) causing autosomal recessive PBS/urinary bladder disease. Functional consequence: loss of M3 muscarinic receptor-mediated detrusor contraction → detrusor hyporeflexia/megacystis (PMID:22077972; PMID:31441039). - PIEZO1 (HGNC:26940) — chr 16q24.3; compound heterozygous loss-of-function affecting mechanosensitive channel gating in bladder smooth muscle (PMID:38184690). - FLNA (HGNC:3754) — Xq28; hemizygous missense variants in surviving adult males, affecting the actin-crosslinking/mechanosensing scaffold function of filamin A in smooth muscle, altering β1-integrin binding (PMID:32085749). This is the only reported X-linked mechanism and is of particular interest given PBS's strong male bias. - HNF1B (HGNC:11630) — rare/uncommon; functionally normal variant found in a small fraction, so its causal role is doubtful (PMID:22114815). - ACTA2 (HGNC:130), ACTG2 (HGNC:144), STIM1* (HGNC:11386) — single-case/single-family candidate genes overlapping with the visceral myopathy/megacystis-microcolon spectrum (PMID:24998021 for ACTA2 + congenital mydriasis + cerebrovascular anomalies).
Variant classification/type: Reported variants span missense (majority), frameshift/truncating, and one CNV report (16p11.2 duplication). Most are ultra-rare/private, reported in single consanguineous families or trios; population allele frequencies in gnomAD are expected to be extremely low or absent given the rarity and severity. No pathogenic variant to date is common enough to be a major population risk allele.
Somatic vs. germline: All reported PBS variants are germline (constitutional).
Functional consequences: Loss-of-function is the consistent mechanism across CHRM3, PIEZO1, and FLNA — i.e., PBS mechanistically converges on impaired smooth-muscle contractility/mechanotransduction in the developing bladder wall, whether via loss of the contraction-triggering receptor (CHRM3), loss of stretch-sensing (PIEZO1), or loss of the cytoskeletal mechanosensing scaffold (FLNA).
Modifier genes / genetic heterogeneity: No formal modifier genes are established; the syndrome is genetically heterogeneous, and "the currently suggested candidate genes [do not] fit an X-linked recessive mode of inheritance" as a class (except FLNA), and functional data are lacking for many variants.
Epigenetic information: Limited to a single case report describing loss of DNA methylation at 6q24 (TNDM locus), IGF2R, DIRAS3, and PEG1 in the PBS-affected member of a discordant monozygotic twin pair, with normal methylation in the healthy co-twin — suggestive of a possible epigenetic/imprinting contribution in at least some sporadic cases, though not replicated at scale.
Chromosomal abnormalities: A 16p11.2 duplication case report exists (PMC8496350); PBS is not classically associated with common aneuploidy syndromes, though it has occasionally been reported comorbid with Down syndrome and other chromosomal anomalies in case literature (not systematically quantified in the sources reviewed here).
Causal chain (synthesized from mesenchymal-defect and obstructive-uropathy theories, plus molecular data):
Upstream vs. downstream: The bladder-wall contractile/mechanotransduction defect (molecular lesions) and/or primary mesenchymal patterning defect is upstream; megacystis, abdominal wall deficiency, and cryptorchidism are best modeled as parallel (not strictly sequential) downstream consequences of the shared upstream mesenchymal/myogenic insult, with oligohydramnios → pulmonary hypoplasia and chronic urinary stasis → CKD/ESRD as further downstream cascades.
Cell types and biological processes involved (suggested ontology terms — verify via OAK before KB use): - Cell types: bladder detrusor smooth muscle cell, ureteral smooth muscle cell, urothelial cell, gubernacular mesenchymal cell, prostatic epithelial/stromal cell, myofibroblast (fibrotic remodeling) - Biological processes (GO): smooth muscle contraction (GO:0006939), detection of mechanical stimulus involved in smooth muscle contraction, acetylcholine receptor signaling pathway, actin cytoskeleton organization, extracellular matrix organization / collagen fibril organization (fibrotic remodeling), testis descent
Protein dysfunction: - CHRM3 — loss-of-function/truncation → reduced/absent G-protein-coupled muscarinic signaling in detrusor smooth muscle. - PIEZO1 — loss-of-function → reduced pressure-induced channel open probability (mechanosensation failure), rescuable in vitro by the small-molecule PIEZO1 agonist Yoda1 (PMID:38184690). - FLNA — altered mechanosensing scaffold function; PBS-associated variants enhance binding to β1-integrin cytoplasmic tails within the Ig19–21 stretch-sensing region, implying a gain- or altered-function mechanotransduction defect rather than simple loss of protein (PMID:32085749).
Metabolic changes: Not a primary feature; secondary uremic metabolic derangement occurs in advanced CKD/ESRD.
Immune system involvement: Not a primary immune-mediated disorder; recurrent UTI (in ~80% of patients) reflects urinary stasis/reflux rather than primary immunodeficiency.
Tissue damage mechanisms: Progressive fibrous/collagen replacement of smooth muscle (a fibrotic remodeling process) in bladder and ureter walls is the dominant tissue-level pathology; renal parenchymal damage arises from dysplasia (primary) plus obstructive/refluxive/infectious injury (secondary).
Biochemical abnormalities: Loss-of-function of the M3 muscarinic acetylcholine receptor and PIEZO1 mechanosensitive cation channel are the two best-characterized molecular lesions.
Molecular/omics profiling: No large-scale transcriptomic, proteomic, or single-cell atlas data specific to human PBS bladder tissue were identified in this search; the field currently relies on candidate-gene sequencing (WES/WGS in trios/families) and functional electrophysiology (patch-clamp of mutant PIEZO1 channels) rather than omics profiling. A 2023 whole-genome-sequencing study broadened the search for visceral myopathy genes including PBS (PMC10241726) but a comprehensive human PBS-tissue omics dataset does not appear to exist yet — flag as a knowledge gap.
Organ level: - Primary: urinary bladder, ureters, kidneys, prostate, testes, abdominal wall musculature - Secondary/associated: lungs (pulmonary hypoplasia), heart (PDA/VSD/ASD/TOF), gastrointestinal tract (malrotation, atresia, anorectal anomalies, Hirschsprung disease), musculoskeletal system (spine, hips, feet) - Body systems involved: genitourinary, musculoskeletal (abdominal wall + skeleton), respiratory, cardiovascular, digestive
Tissue/cell level: - Detrusor and ureteral smooth muscle (progressively replaced by fibrous/collagenous tissue), urothelium, renal parenchyma (dysplastic), prostatic stroma/epithelium, abdominal wall skeletal muscle (deficient/absent), skin/subcutis (redundant, wrinkled), testicular germinal epithelium (cryptorchid, at risk for impaired spermatogenesis) - Suggested Cell Ontology terms (verify via OAK): smooth muscle cell of detrusor, smooth muscle cell of ureter, urothelial cell, skeletal muscle fiber, myofibroblast
Subcellular level: No PBS-specific subcellular/organelle pathology beyond cytoskeletal/membrane-receptor dysfunction (plasma membrane muscarinic receptor for CHRM3; plasma membrane mechanosensitive channel for PIEZO1; actin cytoskeleton/cortical scaffold for FLNA). Suggested GO Cellular Component terms: plasma membrane (GO:0005886), actin cytoskeleton (GO:0015629).
Localization (UBERON — suggest, verify via OAK): urinary bladder (UBERON:0001255), ureter (UBERON:0000056), kidney (UBERON:0002113), prostate gland (UBERON:0002367), testis (UBERON:0000473), abdominal wall / rectus abdominis (UBERON structures), lung (UBERON:0002048).
Lateralization: Bilateral in the defining features (bilateral cryptorchidism, bilateral hydroureteronephrosis); renal dysplasia severity can be asymmetric between kidneys, and unilateral vs. bilateral abnormal-kidney status is itself a documented prognostic factor (bilateral abnormal kidneys = worse prognosis) (StatPearls NBK544248).
Onset: Congenital in essentially all cases; detectable on second-trimester prenatal ultrasound in many cases (distended bladder, dilated ureters, hydronephrosis, deficient abdominal wall echogenicity), with earlier (first-trimester) detection reported in some cases (PMC3784146).
Onset pattern: The structural anomalies are present from early-to-mid gestation (insidious in utero development rather than acute); clinical presentation at birth can range from an asymptomatic wrinkled abdomen to severe respiratory distress from pulmonary hypoplasia.
Progression / disease stages — Woodard/clinical severity classification (three categories): - Category I (~20%): Severe renal dysplasia → oligohydramnios → severe pulmonary hypoplasia (Potter-sequence-like); most affected infants are stillborn or die within days of birth. - Category II (~40%): Full triad present; renal function may be adequate at birth but is at risk of progressive deterioration over childhood; pulmonary function is typically normal. - Category III (~40%): Incomplete/mild triad features; well-maintained renal function; no pulmonary insufficiency; generally good long-term prognosis, "near normal life."
This has been operationalized into a validated quantitative severity score (RUBACE) correlating with Woodard category (PMID:30113772).
Progression rate/course pattern: Variable — from rapidly fatal (Category I, days) to chronic/lifelong with slow renal functional decline over years-to-decades (Category II/III). Renal replacement therapy in PBS, when needed, begins at a younger median age (7.0 years) than in other congenital obstructive uropathies (9.6 years), implying a somewhat faster renal decline trajectory in the subset that does progress (PMID:28779237).
Disease duration: Lifelong for survivors; not self-limited, though the urologic manifestations can be surgically/medically managed rather than "cured."
Remission patterns: Not applicable in the classic sense; surgical/urologic management (vesicostomy, ureteral reimplantation, abdominoplasty, orchiopexy) improves function and cosmesis but does not reverse the underlying structural/muscular deficiency.
Critical periods / windows for intervention: - Prenatal: vesicoamniotic shunting in carefully selected fetuses (normal karyotype, no other major malformations, preserved renal function by fetal urine electrolyte analysis) may reduce oligohydramnios-driven pulmonary hypoplasia and renal dysplasia (PMID:30018947). - ~6 months of age: the recommended window for orchiopexy (to optimize fertility potential and reduce malignancy risk from prolonged cryptorchidism), often combined with abdominoplasty.
Epidemiology:
- Incidence: contemporary estimates 3.6–3.8 per 100,000 live male births; alternative/older estimates cite 1 in 29,000–50,000 live births overall, or roughly 1 in 35,000–40,000 births.
- Prevalence: Orphanet classifies PBS as an ultra-rare/rare disease (specific point-prevalence banding not separately retrieved in this search — recommend confirming via the Orphanet ORPHA:2970 epidemiology table directly, e.g., with just fetch-reference ORPHA:2970).
Inheritance pattern: For the minority of genetically solved cases: autosomal recessive (CHRM3-related, in consanguineous or biallelic-variant families) is the best-established Mendelian pattern; an X-linked mechanism has now been proposed via FLNA hemizygous variants in surviving adult males, which would be consistent with (though not fully explanatory of) the strong male bias (PMID:32085749). The great majority of sporadic PBS cases have no identified Mendelian cause, and multifactorial/non-genetic (mechanical, epigenetic) contributions are documented (see Section 2).
Penetrance / expressivity: Highly variable expressivity is a hallmark of PBS — even within the same CHRM3-mutant family, phenotype severity varied among six affected brothers; and the disease spectrum spans neonatal lethality to normal adult life (Woodard Categories I–III), indicating incomplete/variable expressivity even for a shared genetic lesion.
Genetic anticipation: Not reported/applicable (no repeat-expansion mechanism identified).
Germline mosaicism: Not specifically documented in the sources reviewed.
Founder effects: Not established; most reported causal variants are private to individual consanguineous families (e.g., the Turkish CHRM3 kindred) rather than population founder alleles.
Consanguinity: A significant contributor in the autosomal recessive (CHRM3) cases specifically — the original CHRM3 kindred was a consanguineous Turkish family.
Carrier frequency: Not established (variants are private/family-specific; no population carrier-frequency data identified).
Population demographics: - Sex ratio: ~95–97% male; females represent <5% of cases and, when affected, typically present with the urinary tract/abdominal wall findings without gonadal involvement (since there are no testes to be cryptorchid). - Race/ethnicity: reported roughly twice as common in Black vs. White populations in some U.S. clinical series (source synthesis, not independently re-verified against a primary epidemiologic study in this search pass — flag for confirmation). - Twinning: ~4× higher incidence in twin gestations vs. singletons. - Maternal age: younger maternal age associated with higher incidence. - Geographic distribution: No endemic geographic clustering identified; case reports span multiple continents (e.g., Sudan, Cameroon, Somalia case series retrieved in this search), consistent with a globally distributed rare congenital disorder rather than a population-specific one.
Clinical/laboratory tests: - Serum creatinine and renal function panel — nadir serum creatinine <0.7 mg/dL in the first year of life is a favorable prognostic marker; creatinine >0.7 mg/dL is an adverse prognostic factor (StatPearls NBK544248). - Urinalysis/urine culture (recurrent UTI monitoring).
Imaging: - Prenatal ultrasound (2nd trimester, occasionally 1st trimester): distended fetal bladder (megacystis), dilated ureters, hydronephrosis, oligohydramnios, deficient abdominal wall musculature/echogenicity. - Postnatal renal/bladder ultrasound: assessment of hydroureteronephrosis severity, bladder wall/capacity, renal parenchymal echogenicity (dysplasia). - Voiding cystourethrogram (VCUG): evaluates vesicoureteral reflux, bladder neck/urethral anomalies (including a dilated prostatic urethra). - Chest radiography: assessment for pulmonary hypoplasia. - Echocardiography: screening for the ~25% rate of cardiac anomalies. - Abdominal imaging: screening for GI anomalies (malrotation etc.).
Functional tests: - Urodynamic studies: demonstrate poor/absent detrusor contractility (detrusor hyporeflexia/acontractility). - Fetal urine electrolyte/biochemistry analysis: used to assess fetal renal function prior to considering vesicoamniotic shunting (a normal fetal urine chemistry profile is one of the stated prerequisites for shunt candidacy).
Genetic testing: - No consensus single-gene or panel test is standard given how few cases are genetically solved; when pursued, whole-exome or whole-genome sequencing is the most informative approach (as used to identify PIEZO1 and FLNA variants), given extensive genetic heterogeneity and the very low yield of any single candidate gene. - Targeted CHRM3 sequencing may be considered specifically in consanguineous families or those with an associated impaired pupillary light reflex. - Karyotype/chromosomal microarray is reasonable to exclude aneuploidy/CNV causes (e.g., the reported 16p11.2 duplication) and is also a prerequisite check before offering fetal intervention (vesicoamniotic shunting requires a normal karyotype).
Clinical diagnostic criteria: PBS is a clinical/radiologic diagnosis based on the triad (deficient abdominal wall musculature + urinary tract dilation with poor contractility + cryptorchidism in males); no formal consensus scoring system exists for diagnosis itself, though the RUBACE score (PMID:30113772) is used for severity grading once diagnosed.
Differential diagnosis: - "Pseudo-prune belly syndrome" — urinary tract findings identical to PBS but with normal testicular position and/or normal (or near-normal) abdominal wall musculature; overlaps clinically with megacystis-megaureter syndrome. - Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome (MMIHS) — shares megacystis, hydronephrosis, and abdominal wall laxity but is distinguished by microcolon and intestinal hypoperistalsis without mechanical obstruction; MMIHS and PBS have been reported within the same family, suggesting a possible shared/overlapping pathogenetic mechanism (visceral myopathy spectrum) (PMC4420383; PMID:15289943). - Hirschsprung disease and chronic intestinal pseudo-obstruction are additional considerations in neonates presenting with abdominal distension and failure to pass meconium.
Screening: No population-based newborn or carrier screening program exists for PBS given its sporadic/heterogeneous genetic basis; case-by-case prenatal ultrasound detection is the primary "screening" modality.
Survival/mortality: - Perinatal mortality: 10–25% in contemporary series (older series report rates as high as 60% before modern neonatal/urologic management); mortality correlates directly with pulmonary hypoplasia severity. - ~40% of PBS infants are born prematurely, and nearly half require mechanical ventilation at birth. - Renal-replacement-therapy population 10-year survival: 85% for PBS vs. 94% for congenital obstructive uropathy and 91% for renal hypoplasia/dysplasia — i.e., PBS patients who reach ESRD have somewhat worse long-term survival than other congenital urologic ESRD etiologies (PMID:28779237).
Morbidity/renal function: - ~30% of survivors develop chronic renal insufficiency or ESRD during childhood/adolescence and may require renal transplantation. - In an adult PBS cohort, roughly 50% had normal eGFR, 20% mild renal impairment, and 30% moderate renal impairment. - Patients with the mildest urinary tract involvement (no true obstruction) can have normal life expectancy.
Complications: Recurrent UTI (~80% of patients), constipation (impaired Valsalva from abdominal wall deficiency), progressive CKD/ESRD, and the complications of associated cardiac/GI/musculoskeletal anomalies.
Recovery/functional potential: Historically (pre-1992), males with PBS were considered universally infertile; with modern management, several men with PBS have fathered children naturally, though fertility remains reduced overall (attributed to cryptorchidism-related impaired spermatogenesis; libido and orgasmic function are typically normal, but retrograde ejaculation is common). Female fertility appears largely preserved, with documented successful pregnancy/vaginal delivery case reports.
Prognostic factors: - Favorable: at least one normal-appearing kidney on ultrasound; nadir serum creatinine <0.7 mg/dL in year 1 of life; Woodard Category III disease. - Unfavorable: bilateral abnormal kidneys, nadir creatinine >0.7 mg/dL, history of pyelonephritis, Woodard Category I disease (severe renal dysplasia + pulmonary hypoplasia).
Prognostic biomarkers: Serum creatinine trajectory in infancy is the best-established simple prognostic biomarker; the RUBACE composite severity score is a validated multidimensional prognostic tool (PMID:30113772).
Pharmacotherapy:
- Prophylactic antibiotics to reduce UTI risk (given the ~80% lifetime UTI rate).
- Antibiotic coverage before any urinary tract instrumentation/manipulation.
- No disease-modifying pharmacotherapy currently exists for the underlying smooth-muscle contractility defect; suggested MAXO term: MAXO:0000647-adjacent pharmacotherapy concepts do not directly apply (chemotherapy), so use NCIT:C15986 (Pharmacotherapy) generically for antibiotic prophylaxis with a therapeutic_agent slot for the specific antibiotic class used.
Advanced/experimental therapeutics: - PIEZO1 agonism (Yoda1): an in-vitro proof-of-concept finding — Yoda1 rescued the channel-gating (NPo) defect of PBS-associated PIEZO1 mutant channels, nominating a potential future small-molecule pharmacologic strategy specific to PIEZO1-associated PBS (PMID:38184690). This is preclinical/in vitro only — no human trials identified. - No gene therapy, cell therapy, RNA-based therapy, or immunotherapy approaches for PBS were identified in this search (consistent with its status as a structural/developmental syndrome rather than a targetable single-pathway disease at present).
Surgical/interventional (the mainstay of management): - Prenatal vesicoamniotic shunting: in carefully selected fetuses (normal karyotype, no other major malformations, preserved fetal renal function by serial urine biochemistry) to relieve bladder distension, potentially reducing oligohydramnios-driven pulmonary hypoplasia and renal dysplasia; outcomes remain "controversial" and shunting benefits a subset of patients rather than all (PMID:30018947 — suggested MAXO term: could map to a fetal surgical intervention MAXO/NCIT surgical-procedure term, verify via OAK). - Cutaneous vesicostomy: temporizing bladder drainage in infancy while awaiting growth for more definitive reconstruction. - Orchiopexy (bilateral): recommended at ~6 months of age to optimize fertility potential and reduce malignancy risk of prolonged cryptorchidism; laparoscopic orchiopexy with spermatic vessel preservation is now the preferred modality. - Urinary tract reconstruction (ureteral reimplantation/tailoring): generally reserved for patients with recurrent febrile UTIs or progressive renal deterioration rather than performed prophylactically in all patients. - Abdominoplasty (abdominal wall reconstruction): often performed concurrently with orchiopexy or urinary reconstruction; beyond cosmesis, may improve effective Valsalva-assisted bladder emptying by restoring abdominal wall tone. - Suggested MAXO terms: MAXO:0000004 (surgical procedure) as a generic parent; more specific NCIT surgical-procedure terms for vesicostomy, orchiopexy, and abdominoplasty should be looked up via OAK/NCIT search before KB entry.
Supportive/rehabilitative care: - Management of constipation (from impaired Valsalva). - Long-term multidisciplinary follow-up: neonatology, pediatric urology, nephrology, cardiology, orthopedics, pulmonology — reflecting the multisystem nature of associated anomalies.
Renal replacement therapy: Hemodialysis or peritoneal dialysis followed by renal transplantation for the ~30% of patients progressing to ESRD; multiple renal transplants have been reported in individual PBS patients over a lifetime (e.g., a reported third renal transplant case, PMC8720038).
Treatment outcomes: Contemporary multidisciplinary management (prenatal detection, selective shunting, staged surgery) is associated with improved survival compared to historical cohorts, though vesicoamniotic shunting benefits only a defined subset of patients meeting strict candidacy criteria.
Treatment strategy/algorithm: Broadly staged as (1) prenatal risk stratification ± shunting, (2) neonatal stabilization (respiratory support for pulmonary hypoplasia, temporizing urinary drainage if needed), (3) infancy: orchiopexy ± abdominoplasty around 6 months, (4) individualized decision for urinary tract reconstruction based on UTI/renal-function trajectory, and (5) lifelong nephrology/urology surveillance with renal replacement therapy as needed.
HUMAN_MODEL_MISMATCH-type knowledge-gap annotation if this disease is curated into the dismech KB, given that current animal/cellular models validate only the urinary-tract component of the triad.HUMAN_MODEL_MISMATCH/KNOWLEDGE_GAP candidate.Note on ontology terms: Per this project's anti-hallucination policy, every HP/GO/CL/UBERON/CHEBI/MAXO/NCIT term suggested above is a candidate only and must be independently verified with OAK (runoak -i sqlite:obo:<ontology> info <ID>) for exact label match before being written into any kb/disorders/ YAML entry.